Incidence of testicular cancer in trans women using gender-affirming hormonal treatment: a nationwide cohort study.

Iris de NieChantal M WiepjesChristel J M de BlokR Jeroen A van MoorselaarGarry L S PigotTim M van der SluisEllis BarbéPatrick van der VoornNorah M van MelloJudith HuirneMartin den Heijer

Published in: BJU international (2021)

Testicular cancer risk in trans women is similar to the risk in cis men. The testicular cancer cases occurred within the first 5 years after commencing hormonal treatment, and the percentage of cases encountered at the time of bilateral orchidectomy was low. As no testicular cancer was observed in trans women with a long follow-up period, long-term hormonal treatment does not seem to increase testicular cancer risk.

Keyphrases

polycystic ovary syndrome
papillary thyroid
germ cell
squamous cell
type diabetes
squamous cell carcinoma
pregnant women
combination therapy
young adults
risk factors
skeletal muscle
replacement therapy
childhood cancer
smoking cessation